GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » 3-Year FCF Growth Rate

Abbott India (BOM:500488) 3-Year FCF Growth Rate : 18.30% (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India 3-Year FCF Growth Rate?

Abbott India's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00.

During the past 12 months, Abbott India's average Free Cash Flow per Share Growth Rate was 35.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 18.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 27.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Abbott India was 197.70% per year. The lowest was -55.50% per year. And the median was 23.00% per year.


Competitive Comparison of Abbott India's 3-Year FCF Growth Rate

For the Drug Manufacturers - General subindustry, Abbott India's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Abbott India's 3-Year FCF Growth Rate falls into.



Abbott India 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Abbott India  (BOM:500488) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Abbott India 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Abbott India's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines